Effect of Teriparatide on Unstable Pertrochanteric Fractures

Table 1

Demographic data of the control and teriparatide group patients.

Parameters	Group A	Group B	value
	Demographic data
Gender			0.122
Male	24 (48%)	10 (32.3%)
Female	26 (52%)	21 (67.7%)
Age at time of operation (yrs)	81.0 ± 8.4	82.3 ± 9.5	0.188
Body height (cm)	157.3 ± 8.5	152.0 ± 7.0	0.004^*
Body weight (Kg)	55.2 ± 10.0	54.1 ± 10.0	0.628
Body mass index (kg/m^2)	22.3 ± 3.5	23.4 ± 3.9	0.201
ASA classification			0.566
ASA I	—	—	—
ASA II	31 (62%)	19 (61.3%)
ASA III	19 (38%)	12 (38.7%)
BMD of contralateral hip	−4.3 ± 1.1	−4.4 ± 1.2	0.796
(-score)

Group A: patients without supplementary pharmacologic treatment.
Group B: patients treated with teriparatide.
Values are shown as mean (standard deviation) or given as the (%).
values for between-group comparisons were determined by the chi-squared test and Fisher’s exact test for nominal variables and Student’s -test for parametric variables.
^*Statistically significant ( value < 0.05).